EUVIMEDEUVIMED entdecken
Crossref

Overcoming Gastrointestinal Barriers in Colon - Targeted Drug Delivery Systems: A Comprehensive Review of Recent Advances and Emerging Technologies

{"name":"Dr. S. Amudha","email":"amudhakrishnakumar@gmail.com","affiliati, {"name":"G. Dhivya Sri","email":"amudhakrishnakumar@gmail.com","affiliat

Future Journal of Pharmaceuticals and Health Sciences · 02.04.2026 · 6 (2) · 1-13

DOI: 10.26452/fjphs.v6i2.551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Journal of Pharmaceuticals and Health Sciences, online erschienen am 02.04.2026. Verfasst von {"name":"Dr. S. Amudha","email":"amudhakrishnakumar@gmail.com","affiliati und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colon - targeted drug delivery systems represent a critical therapeutic approach for treating inflammatory bowel diseases, colorectal cancer, and localized infections. However, the complex physiological environment of the gastrointestinal tract presents nume rous challenges that compromise drug delivery efficiency and therapeutic outcomes. This comprehensive review examines the specific challenges that recent colon drug delivery systems aim to overcome in the gastrointestinal tract and evaluates emerging techn ological solutions. A systematic analysis of recent literature (2020 - 2025) was conducted using multiple databases including SciSpace, PubMed, ArXiv, and Google Scholar. Key challenges identified include pH variability (stomach pH 1.5 - 3.5 vs. colon pH 6.5 - 7 .5), heterogeneous transit times (6 - 70 hours colonic residence), dense microbiome interactions (10¹² - 10¹⁴ bacteria/g content), enzymatic degradation, and mucus barrier penetration. Recent innovations include multi - stimuli responsive carriers, microbiome - tr iggered release systems, muco - penetrating nanoparticles, 3D - printed personalized dosage forms, and reactive oxygen species - responsive polymers. Successful colon targeting requires multi - factorial approaches combining pH - independence, microbiome responsiven ess, and mucus penetration capabilities. Emerging technologies show promise for overcoming traditional limitations, though clinical translation remains challenging due to inter - patient variability and regulatory complexities .

Zitieren

APA

Amudha","email":"amudhakrishnakumar@gmail.com","affiliati, N. S., & Sri","email":"amudhakrishnakumar@gmail.com","affiliat, N. D. (2026). Overcoming Gastrointestinal Barriers in Colon - Targeted Drug Delivery Systems: A Comprehensive Review of Recent Advances and Emerging Technologies. Future Journal of Pharmaceuticals and Health Sciences, 6(2), 1-13. https://doi.org/10.26452/fjphs.v6i2.551

Vancouver

Amudha","email":"amudhakrishnakumar@gmail.com","affiliati NS, Sri","email":"amudhakrishnakumar@gmail.com","affiliat ND. Overcoming Gastrointestinal Barriers in Colon - Targeted Drug Delivery Systems: A Comprehensive Review of Recent Advances and Emerging Technologies. Future Journal of Pharmaceuticals and Health Sciences. 2026;6(2):1-13. doi:10.26452/fjphs.v6i2.551

BibTeX
@article{Amudhaemailamudhakrishnakumargmailcomaffiliati2026,
  author = {Amudha","email":"amudhakrishnakumar@gmail.com","affiliati, "name":"Dr. S. and Sri","email":"amudhakrishnakumar@gmail.com","affiliat, "name":"G. Dhivya},
  title = {Overcoming Gastrointestinal Barriers in Colon - Targeted Drug Delivery Systems: A Comprehensive Review of Recent Advances and Emerging Technologies},
  journal = {Future Journal of Pharmaceuticals and Health Sciences},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {1--13},
  doi = {10.26452/fjphs.v6i2.551}
}
Kostenlos starten →